Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.21.1
Equity Incentive Plan (Tables)
 3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense
   

Three Months Ended
March 31,

(unaudited)

  
    2021     2020  
General and administrative   $ 217,291     $ 70,565  
Sales and marketing     41,406       14,464  
Research and development     70,599       9,505  
Cost of revenues     55,111       2,774  
    $ 384,407     $ 97,308  

 
Schedule of fair value of option grants weighted average assumptions
   

Three Months Ended
March 31,

(unaudited)

  
    2021     2020  
Expected term (in years)     5.8       6.3  
Expected Volatility     54.5 %     40.3 %
Risk-free rate     0.8 %     1.5 %
Dividend rate    
—
      
—
  

 
Schedule of stock option activity
   

Number of

Shares under

Option Plan

     Weighted-Average Exercise Price per Option    

Weighted-

Average

Remaining

Contractual

Life (in years)

  
Outstanding at December 31, 2020     4,211,857     $ 0.76       8.6  
Granted     2,378,915     $ 3.00          
Exercised    
—
     $
—
          
Forfeited and expired     (36,879 )   $ 0.78          
Outstanding at March 31, 2021     6,553,893     $ 1.58       8.6  
Exercisable at March 31, 2021     2,761,490     $ 0.86       8.4  
Vested and expected to vest at March 31, 2021     6,553,893     $ 1.58       8.6